Specialized molecular test for monitoring therapeutic efficacy through detection and quantification of messenger RNA. This test supports treatment response assessment and therapeutic adjustment in clinical practice.
Manufactured by
China
Shanghai Rendu Biotechnology, founded in 2007, is a high-tech enterprise pioneering second-generation molecular diagnostic technology in China. The company develops and manufactures IVD reagents and fully automated instruments for prenatal screening, hand-foot-mouth disease, respiratory pathogens, food safety, and blood testing. ISO13485 certified with 13 registered IVD reagent products and 3 instrument products, serving over 400 medical institutions (70% tertiary hospitals).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 2 relevant products
Diatech Pharmacogenetics srl
Italy · 3 relevant products
OraSure Technologies Inc.
United States · 1 relevant product
CheMOnitor Ltd.
Hungary · 1 relevant product
POCBio (Nexlab Co., Ltd.)
China · 2 relevant products
Shanghai Chemtron Biotech Co.,Ltd.
China · 1 relevant product
Delta Care For Medical Industries
Egypt · 1 relevant product
Hangzhou Biotest Biotech Co., Ltd
China · 1 relevant product
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test for guiding cancer treatment selection and predicting therapeutic drug response. Utilizes DNA methylation analysis to optimize personalized cancer treatment strategies.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
OraSure Technologies Inc. · United States
A test designed to assess medication adherence in HIV-positive patients through biomarker detection. Supports treatment monitoring and optimization of antiretroviral therapy outcomes.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
POCBio (Nexlab Co., Ltd.) · China
A diagnostic test for detecting tumor markers. This product is used in oncology screening and monitoring applications.
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test for detecting tumor markers associated with various cancers. This test is used in oncology screening and monitoring.
Delta Care For Medical Industries · Egypt
A rapid diagnostic test for the detection of tumor markers. Used for screening and monitoring cancer-related biomarkers in clinical settings.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Hangzhou Biotest Biotech Co., Ltd · China
A diagnostic test for detecting tumor markers in patient samples. This test is used in oncology screening and monitoring.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products